RECURRENT GRAY-ZONE LYMPHOMA

Clinical trials for RECURRENT GRAY-ZONE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GRAY-ZONE LYMPHOMA trials appear

Sign up with your email to follow new studies for RECURRENT GRAY-ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New combo therapy tested for aggressive lymphomas

Disease control Completed

This early-stage trial tested a new combination of two immune-based drugs, lenalidomide and blinatumomab, for adults with non-Hodgkin lymphoma that has come back or stopped responding to other treatments. The main goal was to find the safest dose and understand the side effects. …

Matched conditions: RECURRENT GRAY-ZONE LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

RECURRENT GRAY-ZONE LYMPHOMA

Get alerted when new RECURRENT GRAY-ZONE LYMPHOMA trials appear

New combo therapy tested for aggressive lymphomas